当前位置: 首页 >> 检索结果
共有 19838 条符合本次的查询结果, 用时 4.0442334 秒

721. Hydroxychloroquine discontinuation in SLE: a retrospective cohort study with 3-year follow-up.

作者: Milena Delai.;Rachel B Simon.;Eduardo M Cardoso.;Vasileios C Kyttaris.
来源: Rheumatology (Oxford). 2026年65卷1期
To evaluate the incidence and factors associated with SLE flares following HCQ discontinuation.

722. Should all polymyalgia rheumatica be referred to rheumatology? A call for unified stratified specialist care of the GCA-PMR spectrum.

作者: Bhaskar Dasgupta.;Christian Dejaco.;Kornelis van der Geest.;Humphrey Hodgson.;Kenneth J Warrington.
来源: Rheumatology (Oxford). 2026年65卷1期

723. Ten-year cardiovascular risk changes and major adverse events in gout patients.

作者: Byeongzu Ghang.;Jinseok Kim.;Taeuk Kang.;Hyun Jung Kim.
来源: Rheumatology (Oxford). 2026年65卷1期
The long-term interaction between cardiovascular (CV) risk profiles and gout may influence the risk of cardiovascular events. However, the impact of gout and long-term changes in CV risk profile on CV events is unclear.

724. Elevated pre-eclampsia risk in lupus nephritis and antiphospholipid syndrome: a nationwide Spanish registry analysis.

作者: Mario Martín-Portugués.;Jorge Esteban-Sampedro.;Susana Mellor-Pita.;Pablo Tutor de Ureta.;Román Fernández-Guitián.;Ana Huerta.;Guillermo Ruiz-Irastorza.;Luis Dueña-Bartolome.;Ana Royuela.;Alfonso Ortega-de la Puente.;Marina de la Cruz-Echeandía.;Víctor Moreno-Torres.
来源: Rheumatology (Oxford). 2026年65卷1期
Evaluate the association of APS and SLE, focusing on LN, with risk of pre-eclampsia (PE) and PE with severity criteria (PESC).

725. Improving care in lupus pregnancies: utility of educational tools to improve awareness.

作者: Vijaya Prasanna Parimi.;Laura Andreoli.;Vinod Ravindran.
来源: Rheumatology (Oxford). 2026年65卷1期

726. Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis.

作者: Helena Marzo-Ortega.;Iain B McInnes.;Mohamed Sharaf.;Alen Zabotti.;Emmanouil Rampakakis.;Dennis McGonagle.;Ahmed Abogamal.;Pascal Richette.;Georg Schett.
来源: Rheumatology (Oxford). 2026年65卷1期
To evaluate guselkumab efficacy on dactylitis resolution (DR) and enthesitis resolution (ER), and their impact on subsequent disease control, in patients with active psoriatic arthritis (PsA) and prior inadequate response to tumour necrosis factor inhibitors (TNFi-IR).

727. Comment on: Risk of venous thromboembolism in people with rheumatoid arthritis: a population-based study in the UK.

作者: Eirik Ikdahl.
来源: Rheumatology (Oxford). 2026年65卷1期

728. Efficacy and safety of a millimetre wave medical device for pain neuromodulation in peripheral OA: a crossover randomized trial.

作者: Caroline Maindet.;Joris Giai.;Corentin Leroy.;Marion Proust.;Gilliane Lalami.;Isabelle Boudry.;Marlène Thiers.;Jean-Luc Bosson.;Laurent Grange.
来源: Rheumatology (Oxford). 2026年65卷1期
To manage OA-related pain, current guidelines recommend a combination of non-pharmacological and pharmacological treatments. The objective of this study was to assess a millimetre-wave-emitting medical device (MD) for neuromodulation of pain in patients with peripheral OA.

729. Comment on: Risk of venous thromboembolism in people with rheumatoid arthritis: a population-based study in the UK: reply.

作者: Mark D Russell.;Katie Bechman.;Mark Gibson.;Victoria Basey.;Michael Mclean.;Saqib Rana.;Anna Barkaway.;Simon de Lusignan.;Maya H Buch.;James B Galloway.
来源: Rheumatology (Oxford). 2026年65卷1期

730. Lipid-rich pericoronary adipose tissue in systemic lupus erythematosus.

作者: Lévi-Dan Azoulay.;Nadjia Kachenoura.;Khaoula Bouazizi.;Samia Boussouar.;Thomas Broussaud.;Nassim Ait-Abdallah.;Julien Haroche.;Alexis Mathian.;Zahir Amoura.;Alban Redheuil.
来源: Rheumatology (Oxford). 2026年65卷1期

731. Retraction of: Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in systemic lupus erythematosus.

来源: Rheumatology (Oxford). 2025年64卷11期5981页

732. Global epidemiology of spondyloarthritis.

作者: John D Reveille.;Lihi Eder.;Nelly Ziade.;Percival D Sampaio-Barros.;Tae-Hwan Kim.;Nurullah Akkoç.;Matthew A Brown.
来源: Nat Rev Rheumatol. 2025年21卷10期580-598页
The worldwide epidemiology of axial spondyloarthritis (axSpA), psoriatic arthritis (PsA) and peripheral spondyloarthritis, as well as of HLA-B27 and other MHC and non-MHC genes in these diseases, is reviewed herein. The frequency of axSpA is highest in circumpolar groups (such as Sami people and certain Indigenous American groups) and lowest in those of Japanese and African ancestry. The same pattern holds for PsA, although the overall prevalence of PsA seems much lower in East Asia, where it is less frequent than axSpA. The prevalence of PsA in people with psoriasis is increased where rheumatological assessment was carried out and seems to be increasing over time. HLA-B27 remains the most important genetic factor in axSpA susceptibility, although its frequency is lower in African American, South American and Middle Eastern populations than in others. The presence of HLA-B27 and other HLA alleles seems to be important in discerning clinical subsets of SpA and PsA, particularly those characterized by acute anterior uveitis or by axSpA with psoriasis, although these HLA-B27 and other MHC and non-MHC associations are derived from genome-wide association studies and other chip-based studies in large populations. These studies have been carried out mainly in populations of European and East Asian ancestry, and similar data from Latin America, sub-Saharan Africa and South Asia are lacking. This under-representation is an unmet need in applying genetic factors to understand the pathogenesis, diagnosis and classification of SpA and PsA.

733. Unscientific vaccine policy endangers vulnerable patients.

作者: The Lancet Rheumatology.
来源: Lancet Rheumatol. 2025年7卷10期e659页

734. Correction to Lancet Rheumatol 2025; 7: e554-64.

来源: Lancet Rheumatol. 2025年7卷11期e761页

735. Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease.

作者: Dewi Rijnenberg.;Safae Hamkour.;Frank Redegeld.;Helen Leavis.;Joël van Roon.
来源: Lancet Rheumatol. 2025年7卷11期e754-e756页

736. Facilitators influencing participation in digitally-based high-intensity interval training among individuals with axial spondyloarthritis - a qualitative study.

作者: Anna Torell.;Emelie Wiking.;Ingrid Larsson.;M Charlotte Olsson.;Emma Haglund.
来源: BMC Rheumatol. 2025年9卷1期104页
Physical exercise is part of the recommended treatment for individuals with axial spondyloarthritis (axSpA). High-intensity interval training (HIIT) is an effective way to improve cardiovascular health without risk of increased disease activity. Nevertheless, there is a lack of knowledge regarding facilitating factors for digitally-based HIIT among individuals with axSpA.

737. Comment on: Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: reply.

作者: Satoshi Kubo.;Yoshiya Tanaka.
来源: Rheumatology (Oxford). 2026年65卷1期

738. Inborn errors of immunity and AAV: a complex picture.

作者: Clément Triaille.;Marie-Louise Frémond.;Augusto Vaglio.
来源: Nat Rev Rheumatol. 2025年21卷12期752页

739. Reply to 'Inborn errors of immunity and AAV: a complex picture'.

作者: Ahmet Gül.;Ivona Aksentijevich.;Paul Brogan.;Marco Gattorno.;Peter C Grayson.;Seza Ozen.
来源: Nat Rev Rheumatol. 2025年21卷12期753页

740. The epidemiology of RA.

作者: Axel Finckh.
来源: Nat Rev Rheumatol. 2025年21卷12期701-702页
共有 19838 条符合本次的查询结果, 用时 4.0442334 秒